ctDNA monitoring to optimize immunotherapy treatment decisions
Dive into the latest data highlighting ctDNA for immunotherapy treatment response monitoring
Watch Video
Dive into the latest data highlighting ctDNA for immunotherapy treatment response monitoring
Watch Video
In this episode of our Inside the ProActive Study Podcast, Dr. Daniel Brennan gives us his thoughts on: • Why “50% of DSA’s are clinically meaningless” when monitoring for rejection. • His dd-cfDN
Listen Now
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Listen Now
In this episode of our Inside the ProActive Study Podcast, Dr. Daniel Brennan gives us his thoughts on: • Why “50% of DSA’s are clinically meaningless” when monitoring for rejection. • His dd-cfDNA su
Watch Video
Have a question or comment?
Contact UsRead More
Read More
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Watch Video
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about: • His dd-cfDNA “surveillance journey” and protocol development.
Watch Video
Listen Now
In this episode of our Inside the ProActive Study Podcast, Dr. Matthew Cooper shares his insights on: • Utilizing cfDNA alongside DSA and biopsies before implementing his dd-cfDNA surveillance protoc
Watch Video
Learn more about the latest Signatera™ data in high-risk breast cancer: Newly published data from the I-SPY 2 trial reinforcing the utility of ctDNA monitoring
Watch Video
Read More
Souter, V., Prigmore, B., Becraft, E., et al. Obstetrics and Gynecology 2023 Aug 10
Read Publication
Read More
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about his dd-cfDNA “surveillance journey” and protocol development.
Listen Now
Read More
Our expert speakers will discuss the latest data from ASCO 2023 and other recent publications and congresses. This will be followed by a panel discussion on the future directions and implications for
Watch Video
Why to screen for 22q11.2 deletion syndrome during your pregnancy with NIPT.
Watch Video
A guide to discussing a result with low fetal fraction from Panorama NIPT with patients.
Watch Video
Why it’s important to screen for microdeletion syndromes during your pregnancy with NIPT.
Watch Video
Loading More...